✦ LIBER ✦

Tracing the development of acute myeloid leukemia in CBL syndrome

✍ Scribed by Becker, H.; Yoshida, K.; Blagitko-Dorfs, N.; Claus, R.; Pantic, M.; Abdelkarim, M.; Niemoller, C.; Greil, C.; Hackanson, B.; Shiraishi, Y.; Chiba, K.; Tanaka, H.; Miyano, S.; Dohner, K.; Schnittger, S.; Henneke, P.; Niemeyer, C. M.; Flotho, C.; Pfeifer, D.; Ogawa, S.; Lubbert, M.

Book ID: 121697163
Publisher: American Society of Hematology
Year: 2014
Tongue: English
Weight: 59 KB
Volume: 123
Category: Article
ISSN: 0006-4971
DOI: 10.1182/blood-2013-10-533844

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

CBL mutation in chronic myelomonocytic l

CBL mutation in chronic myelomonocytic leukemia secondary to familial platelet disorder with propensity to develop acute myeloid leukemia (FPD/AML)

✍ Shiba, N.; Hasegawa, D.; Park, M.-j.; Murata, C.; Sato-Otsubo, A.; Ogawa, C.; Ma 📂 Article 📅 2012 🏛 American Society of Hematology 🌐 English ⚖ 263 KB

Clinical significance of plasma endostat

Clinical significance of plasma endostatin in acute myeloid leukemia/myelodysplastic syndrome

✍ Raymond Lai; Elihu Estey; Yu Shen; Simona Despa; Hagop Kantarjian; Miloslav Bera 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 62 KB 👁 1 views

Risk of myelodysplastic syndrome and acu

Risk of myelodysplastic syndrome and acute myeloid leukemia in congenital neutropenias

✍ Melvin H. Freedman; Blanche P. Alter 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 78 KB

The Changing Mutational Landscape of Acu

The Changing Mutational Landscape of Acute Myeloid Leukemia and Myelodysplastic Syndrome

✍ Larsson, C. A.; Cote, G.; Quintas-Cardama, A. 📂 Article 📅 2013 🏛 American Association for Cancer Research 🌐 English ⚖ 765 KB

Acute myeloid leukemia developing during

Acute myeloid leukemia developing during imatinib mesylate therapy for chronic myeloid leukemia in the absence of new cytogenetic abnormalities

✍ Attaphol Pawarode; Sheila N.J. Sait; Alain Nganga; Lionel J. Coignet; Maurice Ba 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 171 KB

The BCR/ABL tyrosine kinase inhibitor imatinib mesylate produces a high rate of cytogenetic responses in patients with Philadelphia (Ph)-positive chronic myeloid leukemia (CML), but secondary clonal chromosome abnormalities may develop in Ph-negative cells, and acute myeloid leukemia (AML) has been

Development of myelodysplastic syndrome

Development of myelodysplastic syndrome evolving to acute myeloid leukemia in a patient receiving etanercept for psoriasis

✍ Richelle M. Knudson; Ayalew Tefferi; Mark R. Pittelkow; Mark D.P. Davis 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 59 KB